{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:15:21Z","timestamp":1791918921335,"version":"4.3.4"},"reference-count":29,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,9,19]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Fusion oncogenes can be cancer-defining molecular alterations that are essential for diagnosis and therapy selection.1,2 Rapid and accessible molecular diagnostics for fusion-driven leukemias such as acute promyelocytic leukemia (APL), Philadelphia chromosome\u2013positive acute lymphoblastic leukemia, and chronic myeloid leukemia (CML) are unavailable, creating a barrier to timely diagnosis and effective targeted therapy in many health care settings, including community hospitals and low-resource environments. We developed CRISPR-based RNA-fusion transcript detection assays using SHERLOCK (specific high-sensitivity enzymatic reporter unlocking) for the diagnosis of fusion-driven leukemias. We validated these assays using diagnostic samples from patients with APL and CML from academic centers and dried blood spots from low-resource environments, demonstrating 100% sensitivity and specificity. We identified assay optimizations to enable the use of these tests outside of tertiary cancer centers and clinical laboratories, enhancing the potential impact of this technology. Rapid point-of-care diagnostics can improve outcomes for patients with cancer by expanding access to therapies for highly treatable diseases that would otherwise lead to serious adverse outcomes due to delayed or missed diagnoses.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/blood.2023022908","type":"journal-article","created":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T16:54:35Z","timestamp":1720457675000},"page":"1290-1299","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":16,"title":["CRISPR-based rapid molecular diagnostic tests for fusion-driven leukemias"],"prefix":"10.1182","volume":"144","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0486-3981","authenticated-orcid":false,"given":"Rahul S.","family":"Vedula","sequence":"first","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah Q.","family":"Karp","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2777-532X","authenticated-orcid":false,"given":"Jeremy","family":"Koob","sequence":"additional","affiliation":[{"name":"2Broad Institute of MIT and Harvard, Cambridge, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1976-3705","authenticated-orcid":false,"given":"Felicia","family":"Lim","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2118-6302","authenticated-orcid":false,"given":"Jacqueline S.","family":"Garcia","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4515-8245","authenticated-orcid":false,"given":"Eric S.","family":"Winer","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5781-4529","authenticated-orcid":false,"given":"Marlise R.","family":"Luskin","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3955-7944","authenticated-orcid":false,"given":"Gabriel","family":"Ghiaur","sequence":"additional","affiliation":[{"name":"3Johns Hopkins Medical Institute, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8699-2439","authenticated-orcid":false,"given":"Annette S.","family":"Kim","sequence":"additional","affiliation":[{"name":"4Department of Pathology, Brigham and Women\u2019s Hospital, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan W.","family":"Beppu","sequence":"additional","affiliation":[{"name":"5Fred Hutchinson Cancer Center, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Sala-Torra","sequence":"additional","affiliation":[{"name":"5Fred Hutchinson Cancer Center, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerald","family":"Radich","sequence":"additional","affiliation":[{"name":"5Fred Hutchinson Cancer Center, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2757-2175","authenticated-orcid":false,"given":"Jonathan","family":"Gootenberg","sequence":"additional","affiliation":[{"name":"6McGovern Institute, Cambridge, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Abudayyeh","sequence":"additional","affiliation":[{"name":"6McGovern Institute, Cambridge, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhang","sequence":"additional","affiliation":[{"name":"2Broad Institute of MIT and Harvard, Cambridge, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9822-806X","authenticated-orcid":false,"given":"R. Coleman","family":"Lindsley","sequence":"additional","affiliation":[{"name":"1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"4","key":"2024091915210721800_bib1","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrc2091","article-title":"The impact of translocations and gene fusions on cancer causation","volume":"7","author":"Mitelman","year":"2007","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"2024091915210721800_bib2","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nrc3947","article-title":"The emerging complexity of gene fusions in cancer","volume":"15","author":"Mertens","year":"2015","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"2024091915210721800_bib3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1300874","article-title":"Retinoic acid and arsenic trioxide for acute promyelocytic leukemia","volume":"369","author":"Lo-Coco","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"2024091915210721800_bib4","doi-asserted-by":"crossref","first-page":"853","DOI":"10.3324\/haematol.2009.017962","article-title":"Early hemorrhagic death before starting therapy in acute promyelocytic leukemia: association with high WBC count, late diagnosis and delayed treatment initiation","volume":"95","author":"Breccia","year":"2010","journal-title":"Haematologica"},{"issue":"4","key":"2024091915210721800_bib5","first-page":"4061","article-title":"Early mortality in acute promyelocytic leukemia: potential predictors","volume":"15","author":"Chen","year":"2018","journal-title":"Oncol Lett"},{"issue":"7","key":"2024091915210721800_bib6","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/leu.2011.78","article-title":"Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry","volume":"25","author":"Lehmann","year":"2011","journal-title":"Leukemia"},{"issue":"10","key":"2024091915210721800_bib7","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.3324\/haematol.10874","article-title":"Clinical features and outcomes of 134 Brazilians with acute promyelocytic leukemia who received ATRA and anthracyclines","volume":"92","author":"J\u00e1como","year":"2007","journal-title":"Haematologica"},{"issue":"5","key":"2024091915210721800_bib8","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1182\/blood-2011-04-346437","article-title":"Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid","volume":"118","author":"Park","year":"2011","journal-title":"Blood"},{"issue":"25","key":"2024091915210721800_bib9","doi-asserted-by":"crossref","first-page":"6521","DOI":"10.1182\/blood-2011-05-351403","article-title":"Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"118","author":"Fo\u00e0","year":"2011","journal-title":"Blood"},{"issue":"1","key":"2024091915210721800_bib10","first-page":"37","article-title":"Novel humanitarian aid program: the Glivec International Patient Assistance Program-lessons learned from providing access to breakthrough targeted oncology treatment in low- and middle-income countries","volume":"1","author":"Garcia-Gonzalez","year":"2015","journal-title":"J\u00a0Glob Oncol"},{"key":"2024091915210721800_bib11","first-page":"1","article-title":"The role of humanitarian donations in decreasing preventable mortality from cancer in low-income countries: models to improve access to life-saving medicines","volume":"4","author":"Garcia-Gonzalez","year":"2018","journal-title":"J\u00a0Glob Oncol"},{"key":"2024091915210721800_bib12","doi-asserted-by":"crossref","first-page":"100257","DOI":"10.1016\/j.eclinm.2020.100257","article-title":"The survival of patients enrolled in a global direct-to-patient cancer medicine donation program: the Glivec International Patient Assistance Program (GIPAP)","volume":"19","author":"Umeh","year":"2020","journal-title":"EClinicalMedicine"},{"issue":"11","key":"2024091915210721800_bib13","doi-asserted-by":"crossref","first-page":"e369","DOI":"10.1016\/j.clml.2023.08.001","article-title":"Geographic disparity of outcome in patients with cancer over decades: the surveillance, epidemiology, and end results","volume":"23","author":"Sasaki","year":"2023","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"6387","key":"2024091915210721800_bib14","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1126\/science.aaq0179","article-title":"Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6","volume":"360","author":"Gootenberg","year":"2018","journal-title":"Science"},{"issue":"6336","key":"2024091915210721800_bib15","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1126\/science.aam9321","article-title":"Nucleic acid detection with CRISPR-Cas13a\/C2c2","volume":"356","author":"Gootenberg","year":"2017","journal-title":"Science"},{"issue":"10","key":"2024091915210721800_bib16","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1038\/s41596-019-0210-2","article-title":"SHERLOCK: nucleic acid detection with CRISPR nucleases","volume":"14","author":"Kellner","year":"2019","journal-title":"Nat Protoc"},{"key":"2024091915210721800_bib17","doi-asserted-by":"crossref","first-page":"4659","DOI":"10.1038\/srep04659","article-title":"A\u00a0simple, inexpensive method for preparing cell lysates suitable for downstream reverse transcription quantitative PCR","volume":"4","author":"Shatzkes","year":"2014","journal-title":"Sci Rep"},{"issue":"2","key":"2024091915210721800_bib18","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1182\/bloodadvances.2021005642","article-title":"Practice patterns and real-life outcomes for patients with acute promyelocytic leukemia in the United States","volume":"6","author":"Bewersdorf","year":"2022","journal-title":"Blood Adv"},{"issue":"12","key":"2024091915210721800_bib19","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1038\/leu.2009.183","article-title":"High dose ara-C in the treatment of newly\u00a0diagnosed acute promyelocytic leukemia: long-term results of the German AMLCG","volume":"23","author":"Lengfelder","year":"2009","journal-title":"Leukemia"},{"issue":"6","key":"2024091915210721800_bib20","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.ejca.2013.11.023","article-title":"Management and treatment results in patients with acute promyelocytic leukaemia (APL) not enrolled in clinical trials","volume":"50","author":"Micol","year":"2014","journal-title":"Eur J Cancer"},{"issue":"22","key":"2024091915210721800_bib21","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1182\/blood-2015-12-689059","article-title":"Paper or plastic? BCR-ABL1 quantitation and mutation detection from dried blood spots","volume":"127","author":"Sala Torra","year":"2016","journal-title":"Blood"},{"issue":"9","key":"2024091915210721800_bib22","doi-asserted-by":"crossref","first-page":"e0002267","DOI":"10.1371\/journal.pgph.0002267","article-title":"Rapid detection of myeloid neoplasm fusions using single-molecule long-read sequencing","volume":"3","author":"Sala-Torra","year":"2023","journal-title":"PLOS Glob Public Health"},{"issue":"4","key":"2024091915210721800_bib23","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41587-020-0407-5","article-title":"Targeted nanopore sequencing with Cas9-guided adapter ligation","volume":"38","author":"Gilpatrick","year":"2020","journal-title":"Nat Biotechnol"},{"issue":"41","key":"2024091915210721800_bib24","doi-asserted-by":"crossref","first-page":"25722","DOI":"10.1073\/pnas.2010196117","article-title":"Ultrasensitive CRISPR-based diagnostic for field-applicable detection of Plasmodium species in symptomatic and asymptomatic malaria","volume":"117","author":"Lee","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2024091915210721800_bib25","doi-asserted-by":"crossref","first-page":"5921","DOI":"10.1038\/s41467-020-19097-x","article-title":"Streamlined inactivation, amplification, and Cas13-based detection of SARS-CoV-2","volume":"11","author":"Arizti-Sanz","year":"2020","journal-title":"Nat Commun"},{"issue":"9","key":"2024091915210721800_bib26","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/s41579-021-00598-5","article-title":"The importance of molecular diagnostics for infectious diseases in low-resource settings","volume":"19","author":"Okeke","year":"2021","journal-title":"Nat Rev Microbiol"},{"issue":"8","key":"2024091915210721800_bib27","doi-asserted-by":"crossref","first-page":"5278","DOI":"10.1021\/acs.analchem.9b00073","article-title":"High-fidelity and rapid quantification of miRNA combining crRNA programmability and CRISPR\/Cas13a trans-cleavage activity","volume":"91","author":"Shan","year":"2019","journal-title":"Anal Chem"},{"issue":"51","key":"2024091915210721800_bib28","doi-asserted-by":"crossref","first-page":"e1905311","DOI":"10.1002\/adma.201905311","article-title":"CRISPR\/Cas13a-powered electrochemical microfluidic biosensor for nucleic acid amplification-free miRNA diagnostics","volume":"31","author":"Bruch","year":"2019","journal-title":"Adv Mater"},{"issue":"7","key":"2024091915210721800_bib29","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/s41551-021-00760-7","article-title":"CRISPR-based diagnostics","volume":"5","author":"Kaminski","year":"2021","journal-title":"Nat Biomed Eng"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/144\/12\/1290\/2242669\/blood_bld-2023-022908-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/144\/12\/1290\/2242669\/blood_bld-2023-022908-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T12:37:49Z","timestamp":1726749469000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/144\/12\/1290\/516865\/CRISPR-based-rapid-molecular-diagnostic-tests-for"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,19]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,9,19]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2023022908","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,19]]}}}